|
[1]MARCON PDS, TOVO CV, KLIEMANN DA, et al.Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus:A retrospective cohort study[J].World JGastroenterol, 2018, 24 (5) :613-622.
|
|
[2]CASTVEN D, FISCHER M, BECKER D, et al.Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas[J].Oncotarget, 2017, 8 (30) :48688-48700.
|
|
[3]PENNISI E.Cancer therapies use a little help from microbial friends[J].Science, 2013, 342 (6161) :967-971.
|
|
[4]TREMAROLI V, BACKHED F.Functional interactions between the gut microbiota and host metabolism[J].Nature, 2012, 71 (7415) :242-249.
|
|
[5]CONLON MA, BIRD AR.The impact of diet and lifestyle on gut microbiota and, human health[J].Nutrients, 2015, 7 (1) :17-44.
|
|
[6]SEKI E, SCHNABL B.Role of innate immunity and the microbiota in liver fibrosis:Crosstalk between the liver and gut[J].J Physiol, 2012, 590 (3) :447-458.
|
|
[7]COMPARE D, COCCOLI P, ROCCO A, et al.Gut-liver axis:The impact of gut microbiota on non alcoholic fatty liver disease[J].Nutr Metab Cardiovasc Dis, 2012, 22 (6) :471-476.
|
|
[8]CHASSAING B, ETIENNE-MESMIN L, GEWIRTZ AT.Microbiota-liver axis in hepatic disease[J].Hepatology, 2014, 59 (1) :328-339.
|
|
[9]SZABO G.Gut-liver axis in alcoholic liver disease[J].Gastroenterology, 2015, 148 (1) :30-36.
|
|
[10]SCHNABL B, BRENNER DA.Interactions between the intestinal microbiome and liver diseases[J].Gastroenterology, 2014, 146 (6) :1513-1524.
|
|
[11]LLORENTE C, SCHNABL B.The Gut microbiota and liver disease[J].Cel Mol Gastroenterol Hepatol, 2015, 1 (3) :275-284.
|
|
[12]HUANG R, NI JJ, GAO Y.The association between the intestinal microbiota-lipopolysaccharide-Toll-like receptor 4 axis and hepatocellular carcinoma[J].J Clin Hepatol, 2018, 34 (6) :1325-1328. (in Chinese) 黄蓉, 倪加加, 高毅.肠道菌群-脂多糖-Toll样受体4轴与肝细胞癌的关系[J].临床肝胆病杂志, 2018, 34 (6) :1325-1328.
|
|
[13]MITTAL S, EL-SERAG HB.Epidemiology of hepatocellular carcinoma:Consider the population[J].J Clin Gastroenteroly, 2013, 47 (Suppl) :s2-s6.
|
|
[14]ZHANG HL, YU LX, YANG W, et al.Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats[J].J Hepatol, 2012, 57 (4) :803-812.
|
|
[15]DAPITO D, MENCIN A, GWAK GY, et al.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J].Cancer Cell, 2012, 21 (4) :504-516.
|
|
[16]REN Z, LI A, JIANG J, et al.Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma[J].Gut, 2018, 68 (6) :1014-1023.
|
|
[17]PANT K, SARAYA A, VENUGOPAL SK.Oxidative stress plays a key role in butyrate-mediated autophagy via Akt/m TORpathway in hepatoma cells[J].Chem Biol Interact, 2017, 273:99-106.
|
|
[18]DARNAUD M, FAIVRE J, MONIAUX N.Targeting gut flora to prevent progression of hepatocellular carcinoma[J].J Hepatol, 2013, 58 (2) :385-387.
|
|
[19]YANG J, ZHANG JX, WANG H, et al.Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling[J].World J Gastroenterol, 2012, 18 (23) :2938-2947.
|
|
[20]EIRO N, ALTADILL A, JUAREZ L M, et al.Toll-like receptors3, 4 and 9 in hepatocellular carcinoma:Relationship with clinicopathological characteristics and prognosis[J].Hepatol Res, 2014, 44 (7) :769-778.
|
|
[21]LIU WT, JING YY, YU GF, et al.Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma[J].Cancer Letters, 2015, 358 (2) :136-143.
|
|
[22]WANG L, ZHU R, HUANG Z, et al.Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma[J].Dig Dis Sci, 2013, 58 (8) :2223-2236.
|
|
[23]HOU J, LU Y, ZHANG DK.Association between intestinal dysbacteriosis and liver diseases[J].J Clin Hepatol, 2018, 34 (5) :1128-1132. (in Chinese) 候静, 路越, 张德凯.肠道菌群失调与肝脏疾病的关系[J].临床肝胆病杂志, 2018, 34 (5) :1128-1132.
|
|
[24]YANG J, LI M, ZHENG QC.Emerging role of Toll-like receptor 4 in hepatocellular carcinoma[J].J Hepatocell Carcinoma, 2015, 2:11-17.
|
|
[25] DAPITO DH, MENCIN A, GWAK GY, et al.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J].Cancer cell, 2012, 21 (4) :504-516.
|
|
[26]ZHANG Z, WANG D, QIAO S, et al.Metabolic and microbial signatures in rat hepatocellular carcinoma treated with caffeic acid and chlorogenic acid[J].Sci Rep, 2017, 7 (1) :4508.
|
|
[27]YAMADA S, TAKASHINA Y, WATANABE M, et al.Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice[J].Oncotarget, 2018, 9 (11) :9925-9939.
|
|
[28]YOSHIMOTO S, LOO TM, ATARASHI K, et al.Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome[J].Nature, 2013, 499 (7456) :97-101.
|
|
[29]TONG LC, WANG Y, WANG ZB, et al.Propionate ameliorates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress[J].Front Pharmacol, 2016, 7:253.
|
|
[30]LI J, SUNG CY, LEE N, et al.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice[J].Proc Natl Acad Sci U S A, 2016, 113 (9) :e1306-e1315.
|
|
[31]BINDELS LB, PORPORATO P, DEWULF EM, et al.Gut microbiota-derived propionate reduces cancer cell proliferation in the liver[J].Br J Cancer, 2012, 107 (8) :1337-1344.
|
|
[32]ZHOU SL, ZHOU ZJ, HU ZQ, et al.Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib[J].Gastroenterology, 2016, 150 (7) :1646-1658.
|
|
[33]CHEW V, CHEN J, LEE D, et al.Chemokine-driven lymphocyte infiltration:An early intratumoural event determining longterm survival in resectable hepatocellular carcinoma[J].Gut, 2012, 61 (3) :427-438.
|
|
[34]HU Z, LUO D, WANG D, et al.IL-17 Activates the IL-6/STAT3 signal pathway in the proliferation of hepatitis B virusrelated hepatocellular carcinoma[J].Cell Physiol Biochem, 2017, 43 (6) :2379-2390.
|
|
[35]YE J, LIVERGOOD RS, PENG G.The role and regulation of human Th17 cells in tumor immunity[J].Am J Pathol, 2013, 182 (1) :10-20.
|
|
[36]GAO C.Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma[J].World J Hepatol, 2016, 8 (27) :1119-1127.
|
|
[37]OGINO S, NISHIHARA R, VANDERWEELE TJ, et al.Review article:The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine[J].Epidemiology, 2016, 27 (4) :602-611.
|
DownLoad: